RedHill (RDHL) Down on Unsatisfactory Data From COVID-19 Study


RedHill (RDHL) posts preliminary top-line data from a phase II/III study evaluating opaganib in hospitalized patients with severe COVID-19 pneumonia....... Read more

Bron: Entrepreneur.com: Latest Articles
Tags:
Geplaatst: 15 Sep 2021 - 19:22